Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Rodrigues

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Chemmedchem|February 6, 2020
Design, Synthesis, and Pharmacological Evaluation of First-in-Class Multitarget N-Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα InhibitorsDaniel A Rodrigues, Fabiana S Guerra, Fernanda S Sagrillo, et al.
ACS Omega|May 12, 2025
Exploring the Conformational Effects of <i>N</i>- and <i>C</i>-Methylation of <i>N</i>-AcylhydrazonesLucas Silva Franco, Marina Amaral Alves, Carlos Mauricio R Sant'Anna, et al.
Nature Communications|June 5, 2026
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitorDaniel A Rodrigues, Yu Wang, Juana Goulart Stollmaier, et al.
European Journal of Medicinal Chemistry|January 29, 2013
Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compoundTatiana F Gomes, Thais E T Pompeu, Daniel A Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Chemmedchem|February 6, 2020
Design, Synthesis, and Pharmacological Evaluation of First-in-Class Multitarget N-Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα InhibitorsDaniel A Rodrigues, Fabiana S Guerra, Fernanda S Sagrillo, et al.
ACS Omega|May 12, 2025
Exploring the Conformational Effects of <i>N</i>- and <i>C</i>-Methylation of <i>N</i>-AcylhydrazonesLucas Silva Franco, Marina Amaral Alves, Carlos Mauricio R Sant'Anna, et al.
Nature Communications|June 5, 2026
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitorDaniel A Rodrigues, Yu Wang, Juana Goulart Stollmaier, et al.
European Journal of Medicinal Chemistry|January 29, 2013
Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compoundTatiana F Gomes, Thais E T Pompeu, Daniel A Rodrigues, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
Pageof 2